LMO1 Antibodies

Santa Cruz Biotechnology provides a broad selection of LMO1 monoclonal antibodies for research focused on understanding LMO1's role in various biological processes. LMO1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LMO1, or LIM domain only 1, functions as a key regulator of gene expression and cellular differentiation. LMO1 plays a significant role in nervous system development and has been linked to various cancers, making it a vital research focus. Research involving LMO1 can reveal important insights into oncogenesis and developmental biology. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enabling versatile experimental approaches. Investigating LMO1 expression patterns and interactions can enhance understanding of cellular pathways and disease mechanisms. LMO1 research continues to uncover new aspects of gene regulation and development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of LMO1's biological significance.